Rousselot announces gelatine price increases
Ingredients manufacturer Rousselot has announced a price increase on its gelatine portfolio to balance out spiralling raw material costs.
Archives for February 28, 2012
Chinese service provider files $80m IPO to fund expansion
A Chinese company that offers drug development services using a network of 99 third-party vendors has filed an $80m IPO.
EXCLUSIVE
Create painless devices for quicker regulatory approval, says BD
Reduced-pain injection systems are the key to gaining regulatory approval for new products, according to BD.
EMA calls for companies to trace their heparin to slaughterhouses
Marketing applications for heparin should cover traceability from slaughterhouses and other details of sourcing porcine mucosa, the EMA said.
Charles River & Millipore ally on viral clearance study technology
Charles River has partnered with EMD Millipore to improve the consistency of the viral clearance studies it offers clients.
Almost 30% of biopharma CEOs insourced work in ’11; survey
Almost 30 per cent of biopharma companies have insourced previously outsourced work in the past year, a PwC survey of CEOs found.
Quintiles sets sights on Russian R&D
Quintiles is driving its clinical development services in the Russian Federation through a new alliance with Russian Venture Company (RVC).